2010西湖医药国际会议——转化医学(中国·杭州)

作者:   2010-03-01
字体大小:
  • 会议时间: 2010-06-24至 2010-06-26
  • 会议地点: 杭州市
  • 电话:0571-8697193,86971817,86971897
  • 传真:0571-86971429
  • 联系人:王艳阳\金惠娟
  • Email: westlakeconference@zcni.org
  • 联系地址:杭州市凯旋路268号浙江大学华家池校区浙江加州国际纳米技术研究院
  • 会议网址:http://www.zcni.org/westlakeconference

平行会议三:抗体与医学 (分会主席:朱祯平、华绍炳)

随着市场上大批“重磅炸弹”式抗体药物取得的高成功率,单克隆抗体近年来已经成为一类用来治疗诸如癌症、感染性疾病和炎症性疾病的新型药物。这种现象很大程度上取决于抗体人源化技术和全人源抗体技术的发展。本分会的演讲内容将包括有关抗体技术最新的发展动向、临床应用、抗体生产、诊断应用以及知识产权等话题。

Zhenping Zhu, MD, Ph.D.

Vice President and Global Head, Protein Sciences and Design, Novartis Biologics

Talk title: Researching and developing next generation of antibody-based therapeutics

S. Benjamin Hua, Ph.D.

Adjunct Professor, ZCNI; President & CEO, Avalon BioSciences

Yajun Guo, Ph.D.

Director, SMMU Cancer Institute, Shanghai; President, Chinese Antibody Engineering Center

Talk title: New version of humanized antibody for anti-cancer therapy

Peter Luo, Ph.D.

Director, Vaccine and Biologics Research, Merck & Co., Inc.

Talk title: Development of therapeutic antibodies using adaptor-directed display of designer antibody libraries

Maurice Zaudeer, Ph.D.

President and CEO, Vaccinex, Inc.

Talk title: Therapeutic antibodies selected from immunoglobulin gene libraries expressed in mammalian cells

Cheng-I Wang, Ph.D.

Principle Investigator, Biomedical Sciences, Singapore

Talk title: Therapeutic antibody against emerging infectious diseases

Larry Witte, Ph.D.

Vice President, ImClone Systems, Eli Lilly

Talk title: Targeting cancer with therapeutic antibodies

Jaumes Pons, Ph.D.

Vice President & CSO, Rinat Pharmaceuticals, Pfizer

Talk title: Tanezumab: NGF antibodies as a new mechanism for pain control

Li Yan, Ph.D.

Director, Clinical Oncology, Merck & Co., Inc.

Talk title: Clinical Development of Antibody Therapeutics in Oncology

Cline Wood, Ph.D.

CSO, Bayer Schering

Talk title: Building a biologics pipeline with antibodies, coagulation factors and HTP optimization

Joe Zhou, Ph.D.

Visiting Professor, Peking University; CEO, Genor BioPharma, Wison Group

Talk title: Biopharmaceutical: the way forward

James Zhu, JD, Ph.D., MBA

Partner, Perkins Coie, LLC

Talk title: The complexity of IP issues surrounding therapeutic antibodies and technologies thereof

Guoliang Yu, Ph.D.

President and CEO, Epitomics, Inc.

Talk title: Better antibodies, better science, better life: applications of RabMabs

编辑:   

分页: [ 1 ]   [ 2 ]   [ 3 ]   [ 4 ]   [ 5 ]  
声明:

1.丁香会议频道仅负责发布会议信息,如需参会、获取邀请函或会议日程,请与主办单位联系

2.部分会议信息来自互联网,如您发现信息有误,请联系meeting@dxy.cn纠错

3.如您发现信息不全,可点击Google搜索更多

4.更多服务信息请点击这里

以下网友留言只代表网友个人观点,不代表网站观点

网友评论